SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Recent filings
Filed 2026-04-08 15:25
Tx date 2026-04-02 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-21,150
-5,000 vol
$4.23 each 		37,758
Filed 2026-04-08 15:24
Tx date 2026-04-08 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-41,914
-10,000 vol
$4.19 each 		27,758
Older filings
Filed 2026-03-13 11:48
Tx date 2026-03-09 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-19,924
-5,000 vol
$3.98 each 		42,758
Filed 2026-03-02 11:04
Tx date 2026-02-26 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-20,514
-5,000 vol
$4.10 each 		57,758
Filed 2026-03-02 11:03
Tx date 2026-02-26 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-20,639
-5,000 vol
$4.13 each 		62,758
Filed 2026-03-02 11:00
Tx date 2026-03-02 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-38,517
-10,000 vol
$3.85 each 		47,758
Filed 2026-02-23 12:36
Tx date 2026-02-20 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-42,914
-9,980 vol
$4.30 each 		67,758
Filed 2026-02-23 12:35
Tx date 2026-02-19 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-86.00
-20 vol
$4.30 each 		77,738
Filed 2026-02-23 12:34
Tx date 2026-02-19 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-41,773
-10,000 vol
$4.18 each 		77,758
Filed 2026-02-23 12:33
Tx date 2026-02-18 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-41,312
-10,000 vol
$4.13 each 		87,758
Filed 2026-02-16 13:05
Tx date 2026-02-12 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-39,958
-10,000 vol
$4.00 each 		97,758
Filed 2025-12-09 13:57
Tx date 2024-01-08 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,977
+2,000 vol
$1.99 each 		2,000
Filed 2025-12-09 13:55
Tx date 2024-01-08 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,977
+2,000 vol
$1.99 each
Filed 2025-12-09 13:30
Tx date 2025-12-04 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$212,000
+100,000 vol
$2.12 each 		107,758
Filed 2025-12-09 13:23
Tx date 2025-12-04 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Holder: Fig Advisory LLC (Indirect Ownership)
Options
51 - Exercise of options 		$-212,000
-100,000 vol
$2.12 each 		0
Filed 2024-01-15 15:18
Tx date 2024-01-08 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,977
+2,000 vol
$1.99 each
Filed 2024-01-08 13:59
Tx date 2024-01-08 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,977
+2,000 vol
$1.99 each
Filed 2025-05-20 11:47
Tx date 2025-05-16 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$240,000
+60,000 vol
$4.00 each 		335,000
Filed 2024-06-12 18:50
Tx date 2024-06-05 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$89,500
+50,000 vol
$1.79 each 		275,000
Filed 2024-03-28 20:49
Tx date 2024-03-28 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Warrants
15 - Acquisition or disposition under a prospectus 		$8,637
+2,879 vol
$3.00 each 		2,879
Filed 2024-03-28 20:43
Tx date 2021-09-09 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2024-03-28 20:42
Tx date 2024-03-28 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus 		$13,531
+5,758 vol
$2.35 each 		5,758
Filed 2024-03-28 20:41
Tx date 2021-09-09 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2024-01-15 15:18
Tx date 2024-01-08 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,977
+2,000 vol
$1.99 each 		2,000
Filed 2024-01-08 13:59
Tx date 2024-01-08 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,977
+2,000 vol
$1.99 each
Filed 2024-01-08 13:59
Tx date 2024-01-08 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,977
+2,000 vol
$1.99 each 		2,000
Filed 2024-01-08 13:56
Tx date 2021-09-09 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2023-05-24 11:53
Tx date 2023-05-23 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$80,500
+50,000 vol
$1.61 each 		225,000
Filed 2023-02-24 21:42
Tx date 2023-02-22 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$48,500
+25,000 vol
$1.94 each 		175,000
Filed 2022-11-17 17:04
Tx date 2022-11-15 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$87,000
+50,000 vol
$1.74 each 		150,000
Filed 2022-04-18 12:44
Tx date 2022-04-12 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$110,000
+50,000 vol
$2.20 each 		100,000
Filed 2021-09-16 16:09
Tx date 2021-09-13 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$105,000
+50,000 vol
$2.10 each 		50,000
Filed 2021-09-16 16:08
Tx date 2021-09-09 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-09-16 16:07
Tx date 2021-09-09 		$NGEN
NervGen Pharma Corp. 		McKerracher, Krista
4 - Director of Issuer
Holder: Fig Advisory LLC (Indirect Ownership)
Options
00 - Opening Balance-Initial SEDI Report 		100,000